This week was rather AI—Insilico’s AI-designed anemia drug entered Phase I trials, Ginkgo opened up cloud access to its robotic labs where you can submit experiments in plain English, Eli Lilly revealed it's using AI-powered digital twins (of its factory) to optimize GLP-1 production, and another AI diagnostic system got FDA clearance for stroke detecti…
Weekly Tech+Bio Highlights #76: Neurons, Genomes, and Self-Driving Labs
Lilly uses digital twin AI to scale GLP-1 production, generative genomics—now in Nature, $230M for a rice-grain-sized retinal implant
